Relation Between Multi-Drug Resistance and Apoptosis of HepG2/5-Fu

ZHANG Yang-de,PENG Cheng,LI Nian-feng,GONG Lian-sheng,PENG Jian

DOI: https://doi.org/10.3969/j.issn.1005-8982.2007.21.004

2007-01-01

Abstract:[Objective] To discuss the mechanism of HepG2/5-Fu drug-resistant cell and the relation between apoptosis and drug resistance. [Methods] We analyzed multi-medicine drug resistance the of human liver cancer cell line HepG2/5-Fu, and analyzed the apoptosiss and the tolerance of HepG2/5-Fu cell induced by 5-Fu through AS. And we also analyzed apoptosiss correlation genes expression on the HepG2/5-Fu cell line such as p53, bcl-2, bcl-xl, bax et al. by RT-PCR. [Results] The HepG2/5-Fu cell had the different degree of drug resistance to 5-Fu and other several kinds of commonly used chemotherapy medicine compared with HepG2. Among them, the drug resistance to 5-Fu reached 107.0 times, and paclitaxel reached 49.0 times compared with the drug resistanct of HepG2. ②When treated the HepG2 with the concent ration of 5-Fu (0μmo/L, 30μmo/L or 150μmol/L), the AI was (6.5±1.0)%, (14.0±4.0)% and (20.0±5.0)%, respectively. The apoptosis rate increased 1.2 time and 2.1 time compared with the one not treated with 5-Fu, which were significant (P 0.05). But treated the HepG2/5-Fu with the same concent ration of 5-Fu (30 μmo/L or 150 μmol/L), the AI was (6.7±0.7)%, (7.1 ±2.2)% and (6.5 ±2.0)%. When treated with the same concent ration of 5-Fu (30 μmo/L or 150 μmol/L), the proportion of apoptosis significantly increased and G0/G1 phase increased and S and G2/ M phases were reduced in HepG2 cells , but the proportion of apoptosis and cell cycle did not change in HepG2/5-Fu cells. The expression of bcl-xl, bcl-xs, and bax mRNA significantly increased and the expression of p53 and cpp32 mRNA significantly decreased in resistant HepG2/5-Fu cells, as compared with HepG2 cells by RT-PCR.[Conclusion] wtp53 gene is related to the apoptosis and drug resistance of liver cancer cell HePG2/5-Fu.